Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 18, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2028

Conditions

Sexually Transmitted Diseases, Bacterial

Interventions

DRUG

Doxycycline Pill

200mg Dose

Trial Locations (1)

RECRUITING

University of California, San Francisco/San Francisco General Hospital, San Francisco

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER